Back to search

Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours

Data up to Jan 2025

Published2009
Citations4
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2… (2009) – Acta Oncologica | Metascience Observatory Explorer